BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

GW Pharmaceuticals Ltd. 

Porton Down Science Park

Salisbury  Wiltshire  SP4 0JQ  United Kingdom
Phone: 44-1980-619000 Fax: +44-1980-619111


SEARCH JOBS


Industry
Pharmaceutical






 Company News
GW Pharmaceuticals Provides Update on Cannabinoid Pipeline 3/17/2014 9:04:10 AM    More...
GW Pharmaceuticals Receives Orphan Drug Designation By FDA For Epidiolex® In The Treatment Of Lennox-Gastaut Syndrome 2/28/2014 10:00:08 AM    More...
GW Pharmaceuticals To Present At The Cowen And Company 34th Annual Health Care Conference 2/27/2014 9:29:22 AM    More...
GW Pharmaceuticals To Present At The Leerink Swann and Company Global Healthcare Conference 2/10/2014 12:50:17 PM    More...
GW Pharmaceuticals Reports First Quarter 2014 Financial Results And Operational Progress 2/5/2014 9:23:45 AM    More...
GW Pharmaceuticals To Report Q1 2014 Financial Results And Host Conference Call On 5 February, 2014 1/29/2014 9:02:43 AM    More...
GW Pharmaceuticals Announces The Closing Of Its U.S. Follow-On Offering Of American Depositary Shares (Adss) On The NASDAQ Global Market And Full Exercise Of Underwriters' Option To Purchase Additional AdSs 1/15/2014 8:08:50 AM    More...
Ipsen (IPN.PA) And GW Pharmaceuticals Enter Into Agreement For Ipsen To Promote And Distribute Sativex® In Latin America 1/14/2014 8:51:25 AM    More...
GW Pharmaceuticals Secures $87.9 Million To Fund Epidiolex Development 1/9/2014 6:49:56 AM    More...
GW Pharmaceuticals Files Registration Statement For Proposed Follow-On Offering 12/20/2013 12:21:27 PM    More...
12345678910

//-->